Healthcare Equipment and Supplies
Company Overview of Pharmaco-Kinesis Corporation
Pharmaco-Kinesis Corporation, a medical device company, develops smart local drug delivery systems. Its products include smart drug delivery systems and associated advanced devices to measure biological responses; and Magnetic Breather Pump, a device in the field of local drug delivery that delivers a remotely programmable metronomic combination of tumor fighting medications in single implantable system, as well as is used for the treatment of malignant gliomas and other aggressive brain tumors. The company offers nano-impedance biosensor that detects VEGF-165 (vascular endothelial growth factor), a general biomarker correlating to the presence of a cancerous tumor in the body. Pharmaco-Kine...
10524 South La Cienega Boulevard
Inglewood, CA 90304
Founded in 2006
Key Executives for Pharmaco-Kinesis Corporation
Co-Founder, Chairman, Chief Executive Officer and President
Co-Founder, Chief Oncology Officer and Director
Co-Founder, Chief Medical Officer and Director
Compensation as of Fiscal Year 2015.
Pharmaco-Kinesis Corporation Key Developments
Pharmaco-Kinesis Corporation Appoints Andrew E. Sloan, MD to its Neuro-Oncology Clinical Advisory Board (NOCAB)
Jul 6 15
Pharmaco-Kinesis Corporation announced that Andrew E. Sloan, MD has joined its Neuro-Oncology Clinical Advisory Board (NOCAB).Dr. Sloan is the Peter D Cristal Chair of Neurological Oncology and Director of the Brain Tumor and Neuro-Oncology Center at University Hospitals Case Medical Center in Cleveland, OH, and Professor, and Vice-Chair, Department of Neurological Surgery at the Case Western Reserve University School of Medicine.
Pharmaco-Kinesis Corporation Appoints Robert A. Salata as Chairman of its Infectious Diseases Clinical Advisory Board
Jun 10 15
Pharmaco-Kinesis Corporation announced that Robert A. Salata, MD has accepted an appointment as Chairman of its Infectious Diseases Clinical Advisory Board (IDCAB). Dr. Salata will chair a world-renowned team of infectious disease thought leaders that will provide medical guidance and insight into pathogen detection by the company's revolutionary analog circuit, carbon nanotube biosensor (ACARBTM). Dr. Salata is the Executive Vice Chair of the Department of Medicine and Division Chief of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center (UHCMC) in Cleveland, OH, and effective July 1, 2015 will become Interim Chair of Medicine at UHCMC. In addition, Dr. Salata is Professor of Medicine, International Health, and Biostatistics and Epidemiology at Case Western Reserve University's School of Medicine.
Pharmaco-Kinesis Corporation to Develop Innovative Cloud-Linked Biosensors in Partnership with Ohio Clinical Trials Collaborative of Ohio
Mar 23 15
Pharmaco-Kinesis Corporation announced that it will develop innovative cloud-linked biosensors in partnership with the Ohio Clinical Trials Collaborative of Ohio (OCTC). This undertaking seeks to transform medical practice away from reactive medicine to proactive prevention through real time, continuous cloud-linked monitoring driven by PKC's innovative SMART (Simultaneous Multiplexed Automated Real Time Telemedicine) platform. Additional important applications of PKC's platform technology are food safety testing, environmental monitoring and military biodefense testing. The OCTC will support PKC through medical consulting, research, and clinical trial validation services. The OCTC brings together and manages the medical infrastructure necessary to develop, test and launch innovative medical devices. In conjunction with the OCTC and Ohio's premier research universities and globally-renowned hospitals, PKC will create innovative cloud-linked biosensors that address unmet medical needs. Its cardinal objective is to access the massive medical resources of the state of Ohio to develop a platform technology that helps America transform from the mindset of an 'acute health care system' to one of an 'early detection, cloud-based health care system.' The strategic partnership will draw upon each organization's complementary strengths for biosensor development across a broad spectrum of diseases and infections. The initial focus will be development of biosensors for ovarian cancer (OVASMART), kidney health (RENALSMART), food pathogen and infectious disease (PATHSMART) and traumatic brain injury (NEUROSMART). In addition, the OCTC will support clinical trial development of PKC's Metronomic Biofeedback Pump (MBP), a fully implantable smart infusion device designed to locally deliver chemotherapies or medication over time to a target site. World-renowned medical science researchers and clinicians across Ohio with expertise in oncology, nephrology, infectious disease, neuroscience, and food science will contribute their knowledge and skills to this partnership. These teams will be tasked to identify and validate new biosensors for these and other applications, and support PKC's clinical trial validations that are integral to gaining federal regulatory approval for new medical devices. The effectiveness of this collaboration will be further maximized by drawing upon commercial partners of the OCTC. ClinicalRM will provide clinical site management and data analysis services to the partnership. San Diego-based PacificGMP, an expert in antibody manufacture, will supply the quality antibodies necessary for research and commercialization of PKC's biosensors. When appropriate, the OCTC will lead in identifying academic and institutional grant funding to help defray some of the development costs. Moreover, PKC intends to establish an Ohio operating division to closely tie these activities together with its engineering and technology activities in Los Angeles.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|